К содержанию
Dr. Tara EinullaevaMedical oncologist

Treatment 6 min

Pancreatic cancer: which chemotherapy options are available

Which chemotherapy regimens are used for pancreatic cancer before and after surgery and for metastatic disease, and why genetic testing matters.

Written and medically reviewed by

Dr. Tara Einullaeva

Medical oncologist, 9 years in practice. Credentials · reviewed 19 October 2026

In pancreatic cancer almost everyone needs chemotherapy: after surgery — to lower the risk of the cancer coming back; with a borderline or locally advanced tumor — to make surgery possible; with metastases — to control the disease. Two groups of regimens are used most often: FOLFIRINOX and gemcitabine-based combinations. The choice depends above all on the patient’s general condition.

The main regimens

The American Cancer Society names these options:

Regimen Components When it’s used
FOLFIRINOX 5-fluorouracil, leucovorin, irinotecan, oxaliplatin after surgery; for metastatic disease in patients in good general condition
Gemcitabine + capecitabine two drugs, one of them in tablets after surgery
Gemcitabine + nab-paclitaxel nab-paclitaxel is paclitaxel bound to albumin for metastatic disease
Gemcitabine + cisplatin — for metastatic disease
Gemcitabine alone — for metastatic disease in frailer patients

The American Cancer Society notes that FOLFIRINOX may help people live longer than gemcitabine alone but causes more side effects. Combinations are generally more effective than a single drug, but not every patient can manage them.

Chemotherapy before and after surgery

After surgery. The aim is to destroy any remaining tumor cells. The American Cancer Society states that chemotherapy before and after surgery is usually given for a total of 3 to 6 months, depending on the regimen.

Before surgery. It is often used when the tumor is borderline resectable — close to major blood vessels — and for locally advanced tumors. The aim is to shrink the tumor so that it can be removed. Sometimes radiotherapy is added to chemotherapy.

The decision “can this be operated on” in pancreatic cancer is one of the hardest in oncology. It is best made at a tumor board with an experienced surgeon. How a tumor board works is described in the article “Tumor board”.

How the regimen is chosen

The main factors are:

  • general condition — how active the patient is and how much time they spend in bed;
  • age and other health conditions — heart, kidneys, liver, diabetes;
  • liver function — the tumor can press on the bile ducts; with jaundice, bile flow is restored first (stenting);
  • nutrition and weight — digestion is often disrupted in pancreatic cancer, and this needs to be treated in parallel.

If during treatment you develop a fever of 38 °C (100.4 °F) or higher, jaundice, severe abdominal pain or uncontrollable vomiting, contact your doctor the same day. With chills and fever during chemotherapy, don’t wait — more in the article “Fever during chemotherapy”.

Genetics and targeted drugs

Genetic testing is recommended in pancreatic cancer. Back in 2019, the NCCN guidelines proposed considering a test for inherited mutations for all patients with this tumor; in a Memorial Sloan Kettering study, inherited mutations were found in about 17% of patients.

Treatment depends on the result:

  • an inherited BRCA mutation — if the tumor hasn’t progressed for at least 4 months on platinum chemotherapy, the American Cancer Society names maintenance therapy with olaparib as an option;
  • an NTRK gene fusion — the targeted drugs larotrectinib or entrectinib;
  • a KRAS G12C mutation — adagrasib or sotorasib, usually after other lines;
  • MSI-H / dMMR — immunotherapy may be possible.

The results of an inherited test also matter for relatives. More in the article “BRCA testing: who needs it and why”.

How treatment is tolerated

Common side effects, according to the American Cancer Society: nausea and vomiting, loss of appetite, hair loss, mouth sores, diarrhea or constipation, numbness in the fingers, low white blood cells and platelets. Regimens with irinotecan can cause marked diarrhea — see the article “Diarrhea during chemotherapy”.

It’s important to treat digestive problems and watch your weight at the same time. Many patients need pancreatic enzymes — ask your doctor about them if your stools are fatty, bulky and hard to flush.

How response to treatment is assessed

The response to chemotherapy is assessed by CT every few cycles and by how you feel. The tumor marker CA 19-9 helps track changes if it was raised before treatment, but decisions aren’t made on a single marker value — especially with jaundice, when CA 19-9 can rise without the tumor growing. More in the article “Tumor markers”.

Clinical trials

In pancreatic cancer, clinical trials aren’t a “last chance” but a normal part of the discussion, especially with metastatic disease. Ask your doctor whether there are suitable trials even before first-line treatment starts. More in the article “Clinical trials”.

Jaundice, pain and nutrition

In pancreatic cancer, treating the tumor goes hand in hand with treating its effects — and that matters just as much for how you feel.

Jaundice. A tumor in the head of the pancreas can press on the bile duct. Then the skin and eyes turn yellow, urine darkens, stools become pale and itching appears. Bile flow is restored — most often a stent is placed through an endoscope. Many chemotherapy drugs can’t be given when bilirubin is high, so a stent is sometimes placed before treatment starts. If jaundice returns during chemotherapy or you develop fever with chills, the stent may have become blocked — contact your doctor urgently.

Pain. Pain in the upper abdomen spreading to the back is a common symptom. It is treated with painkillers, and if these aren’t enough, a nerve block or radiotherapy is discussed.

Nutrition. Reduced enzyme production leads to poor absorption of food, bloating, fatty stools and weight loss. Pancreatic enzymes taken with meals noticeably improve digestion. If you are losing weight, discuss nutrition and supplementary nutritional drinks with your doctor — more in the article “Nutrition during chemotherapy”.

Questions to ask your treating doctor

  • Can my tumor be removed now, or after chemotherapy?
  • Why are you suggesting this particular regimen?
  • Has genetic testing been done (inherited and tumor)?
  • How will we assess whether treatment is working?
  • Do I need enzymes and nutritional advice?

If you’ve been diagnosed with pancreatic cancer and want to check whether all the options have been considered, I’ll go through your records at a consultation.

Sources

  1. Chemotherapy for Pancreatic Cancer — American Cancer Society, 2024
  2. Treating Pancreatic Cancer by Stage — American Cancer Society, 2026
  3. Targeted Therapy for Pancreatic Cancer — American Cancer Society, 2026
  4. Germline Testing, Molecular Profiling Now Recommended in NCCN Pancreatic Cancer Guideline — Journal of Oncology Navigation & Survivorship, 2019

Watch me explain this on video

Short videos on my Instagram (in Russian)

Frequently asked questions

This article is for information only and does not replace a consultation with your treating doctor. Decisions about tests and treatment are made by the doctor who looks after you.